Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Extended duration betrixaban in acutely ill medical patients is associated with reduction in fatal or irreversible ischemic or bleeding events compared with standard dose enoxaparin: an APEX substudy Gibson, C. M., Arbetter, D. F., Jain, P., Halaby, R., Chi, G., Nafee, T., Korjian, S., Daaboul, Y., Goldhaber, S. Z., Hull, R. D., Gold, A., Hernandez, A. F., Cohen, A. T., Harrington, R. A. OXFORD UNIV PRESS. 2017: 382
View details for Web of Science ID 000440509301432